African Bundibugyo ebolavirus vaccine candidate to be advanced to clinical trials
CEPI backs Minapharm’s Bundibugyo ebolavirus vaccine candidate, based on ProBioGen’s proprietary MVA-CR19 platform OSLO, Norway, CAIRO and BERLIN,…
Browsing Tag